ARTHROCARE CORP
ARTC
ARTC was delisted on the 29th of May, 2014.
117 hedge funds and large institutions have $1.61B invested in ARTHROCARE CORP in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 31 closing their positions.
53% more capital invested
Capital invested by funds: $1.05B → $1.61B (+$559M)
0% more funds holding
Funds holding: 117 → 117 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 31
40% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 45
78% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $5.92M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$301M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$142M |
| 3 |
PC
Paulson & Co
New York
|
+$94.9M |
| 4 |
WIC
Water Island Capital
New York
|
+$89.8M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$24.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$95.6M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$64.2M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$44.5M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$36.5M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$34.8M |
ARTC Hedge Fund Activity: Q1 2014 in Review
117 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in ARTHROCARE CORP (ARTC) for Q1 2014, worth a combined $1.61B — up 53% from $1.05B a quarter earlier.
Fund positioning in ARTC was balanced in Q1 2014: 31 funds opened new positions, 31 closed out, 27 added to existing stakes and 45 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $301M. The largest seller was HealthCor Management, exiting entirely with an estimated $95.6M sold.
- 117 institutional investors held ARTHROCARE CORP (ARTC) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $1.61B of ARTHROCARE CORP stock for Q1 2014, up 53% quarter-over-quarter.
- 31 funds opened new ARTHROCARE CORP positions in Q1 2014 and 31 closed out, a net change of 0 holders.
- The largest ARTHROCARE CORP buyer in Q1 2014 was JP Morgan Chase, an estimated $301M added.
- The largest ARTHROCARE CORP seller in Q1 2014 was HealthCor Management, an estimated $95.6M sold.
Based on aggregated 13F filings for Q1 2014.